Imunon (IMNN) Current Deferred Revenue (2013 - 2022)
Imunon's Current Deferred Revenue came in at $125,000 for Q3 2022, down 75.0% from $500,000 a year earlier and down 50.0% from the prior quarter.
Powered by 
Analysis
Imunon (IMNN) Current Deferred Revenue (2013 - 2022) Analysis & Trends
At the end of FY2021, Imunon's Current Deferred Revenue was $500,000, unchanged from FY2020.
- Current Deferred Revenue carries a five-year compound annual growth rate of 0.0% (FY2016 to FY2021).
- Going back by year, Current Deferred Revenue was $500,000 in FY2020 (unchanged), $500,000 in FY2019 (unchanged), $500,000 in FY2018 (unchanged) and $500,000 in FY2017 (unchanged).
- The Q3 2022 figure represents the lowest quarterly Current Deferred Revenue in data going back to Q1 2013.
- Year-over-year, Current Deferred Revenue has declined for three consecutive quarters, with an average decline of 18.8% over the last eight quarters.
- Across the past five years, year-over-year decline in Current Deferred Revenue ran from 0.0% in Q4 2021 to 75.0% in Q3 2022.
- Business Quant data shows IMNN's Current Deferred Revenue at $250,000 (Q2 2022), $375,000 (Q1 2022) and $500,000 (Q4 2021) in the three quarters before Q3 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Imunon | 6.02 Mn | 6.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 125,000.00 |
| Jun 30, 2022 | 250,000.00 |
| Mar 31, 2022 | 375,000.00 |
| Dec 31, 2021 | 500,000.00 |
| Sep 30, 2021 | 500,000.00 |
| Jun 30, 2021 | 500,000.00 |
| Mar 31, 2021 | 500,000.00 |
| Dec 31, 2020 | 500,000.00 |
| Sep 30, 2020 | 500,000.00 |
| Jun 30, 2020 | 500,000.00 |
| Mar 31, 2020 | 500,000.00 |
| Dec 31, 2019 | 500,000.00 |
| Sep 30, 2019 | 500,000.00 |
| Jun 30, 2019 | 500,000.00 |
| Mar 31, 2019 | 500,000.00 |
| Dec 31, 2018 | 500,000.00 |
| Sep 30, 2018 | 500,000.00 |
| Jun 30, 2018 | 500,000.00 |
| Mar 31, 2018 | 500,000.00 |
| Dec 31, 2017 | 500,000.00 |
API Access
Imunon Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=IMNN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "IMNN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=IMNN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();